Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
常见问题
Harrow Health 11.875% Senior Notes due 2027 今天的股价是多少?▼
HROWM 当前价格为 $26.03 USD,在过去 24 小时内下跌了 -0.08%。在图表上更密切关注 Harrow Health 11.875% Senior Notes due 2027 股票的表现。
Harrow Health 11.875% Senior Notes due 2027 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 XNAS 交易所,Harrow Health 11.875% Senior Notes due 2027 的股票以代码 HROWM 进行交易。
Harrow Health 11.875% Senior Notes due 2027 去年的营收是多少?▼
Harrow Health 11.875% Senior Notes due 2027 去年的营收为 199.61MUSD。
Harrow Health 11.875% Senior Notes due 2027 去年的净利润是多少?▼
HROWM 去年的净收益为 -17.48MUSD。
Harrow Health 11.875% Senior Notes due 2027 会发放股息吗?▼
是的,HROWM 的股息每 每季度 发放一次。每股最新股息为 0.74 。截至今日,股息率(FWD)% 为 11.41%。
Harrow Health 11.875% Senior Notes due 2027 有多少名员工?▼
截至2026年10月16日,公司共有217名员工。
Harrow Health 11.875% Senior Notes due 2027 属于哪个行业?▼
Harrow Health 11.875% Senior Notes due 2027从事于其他行业。
Harrow Health 11.875% Senior Notes due 2027 何时完成拆股?▼
Harrow Health 11.875% Senior Notes due 2027 最近没有进行任何拆股。